Cardiac Assist Devices And Equipment Industry to Witness 9.2% Growth, Reaching $3.68 Billion by 2029

How large is the cardiac assist devices and equipment market, and what is its growth trajectory?

The cardiac assist devices and equipment market size has grown rapidly in recent years. It will grow from $2.3 billion in 2024 to $2.59 billion in 2025 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to cardiac arrhythmias prevalence, aging population, clinical guidelines and research, minimally invasive procedures.

The cardiac assist devices and equipment market size is expected to see strong growth in the next few years. It will grow to $3.68 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to personalized medicine, global access to healthcare, electrophysiology devices in heart failure management, hybrid procedures. Major trends in the forecast period include 4d mapping and visualization, artificial intelligence (ai) in electrophysiology, regenerative medicine approaches, leadless cardiac pacing.

Get Your Free Sample of The Global Cardiac Assist Devices And Equipment Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2401&type=smp

What are the key forces behind the cardiac assist devices and equipment market’s growth in recent years?

A rise in the prevalence of cardiovascular diseases (CVD) increases the demand for cardiac assist devices and equipment in developed and developing economies. The increasing need for diagnosis, monitoring, early-stage treatment, and prevention of these life-threatening diseases, increases the demand for cardiac assist devices. For instance, according to the American Heart Association, a US-based nonprofit organization, by 2035, 45.1% of the US population is s to have some form of CVD. Total costs of CVD are expected to reach $1.1 trillion in 2035, with direct medical costs projected to reach $748.7 billion and indirect costs estimated to reach $368 billion. Therefore, a rise in the prevalence of cardiovascular diseases is driving the growth of the cardiac assist devices and equipment market.

What are the major segments of the cardiac assist devices and equipment market?

The cardiac assist devices and equipment market covered in this report is segmented –

1) By Type: Ventricular Assist Devices (LVAD), Intra-Aotic Baloon Pumps, Total Artificial Heart

2) By Modality: Transcutaneous, Implantable

3) By Application: Hospital Pharmacies, Ambulatory Surgical Centres, Emergency Services

Subsegments:

1) By Ventricular Assist Devices (LVAD): Implantable LVADs, Externally Powered LVADs, Pediatric LVADs, Other LVADs

2) By Intra-Aortic Balloon Pumps: Disposable Intra-Aortic Balloon Pumps, Reusable Intra-Aortic Balloon Pumps

3) By Total Artificial Heart: Pneumatically Powered Total Artificial Heart, Electrically Powered Total Artificial Heart, Other Total Artificial Heart Types

Order your report now for swift delivery

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Which companies dominate the cardiac assist devices and equipment market?

Major companies operating in the cardiac assist devices and equipment market include Abbot Laboratories, Berlin Heart GmbH, Abiomed Inc., Bivacor Pvt Ltd., Calon Cardio-Technology Ltd., Cardiobridge GmbH, Balton Sp. Z O.O, Cardiac Assist Inc., Braile Biomedica Ltd., Circulite Inc., Cardiokinetix Inc., Evaheart Inc., Fineheart Sarl, Fresenius Medical Care Ag & Co. KGaA, Getinge Ab, GPB Life Science Holdings Llc, Jarvik Heart Inc., Medtronic plc, OregonHeart, Mitiheart Corporation, Procyrion Inc., Relianthreat Inc., Scandinavian Real Heart AB, Senko Medical Instrument Mfg. Co. Ltd., Syncardia Systems LLC, HeartWare International Inc., Cardiac Dimensions Inc., Cardiac Power Innovations, Cardiac Science Corporation, Cardionomic Inc., Carmat SA, CorWave SA, Edwards Lifesciences Corporation, Leviticus Cardio Ltd., LivaNova PLC, MicroMed Cardiovascular Inc., MyoCardioCare Inc., Novacor SA, Orqis Medical Corporation, Terumo Corporation, Thoratec Corporation, Ventracor Limited

What major trends will shape the cardiac assist devices and equipment market during the forecast period?

Major companies operating in the cardiac assist devices and equipment market are developing innovative products such as the CardioMEMS HF System to support the care of more people living with heart failure. CardioMEMS HF System is a cardiac device that wirelessly measures and monitors pulmonary artery pressure and heart rate for patients with heart failure. For instance, in February 2022, Abbott Laboratories, a US-based medical device company received FDA approval for CardioMEMS HF System, a small implantable sensor for heart failure. Healthcare providers can use information from the CardioMEMS HF system to make treatment decisions and manage a patient’s heart failure, possibly helping these patients get care sooner and avoid heart failure-related hospitalizations.

What are the key regional dynamics of the cardiac assist devices and equipment market, and which region leads in market share?

North America was the largest region in global cardiac assist devices and equipment market in 2023. Western Europe was the second-largest region in cardiac assist devices and equipment market. The regions covered in the cardiac assist devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

What Does The Cardiac Assist Devices And Equipment Market Report 2025 Offer?

The cardiac assist devices and equipment market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.

Cardiac assist devices and equipment are electromechanical devices that assist in pumping blood from the heart to the rest of the body. These devices are used either to partially or completely replace the function of a failing heart. They help improve blood circulation, reduce the workload on the heart, and can even provide life-saving assistance in critical situations.

Purchase the exclusive report now to unlock valuable market insights:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2401

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Leave a Reply

Your email address will not be published. Required fields are marked *